As of Feb 12
| 0.00 / 0.00%|
The 16 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 52.87, with a high estimate of 55.52 and a low estimate of 46.75. The median estimate represents a +33.61% increase from the last price of 39.57.
The current consensus among 16 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.